Tag Archives: state health exchanges

The First Day of Obamacare: Is US Pharma Ready?

by Tom Norton For more than three years, the US pharmaceutical industry has known that today would arrive. So this is it. The first day that eligible U.S. citizens can sign up for Obamacare — and enjoy the prospect of prescription drug insurance, effective January 1st, 2014. I have spent the last week surveying many […]
Posted in Guest Blog, healthcare, Legal, Market Access, pricing, R&D, Regulatory, Sales, Strategy | Also tagged , , , , , , , | 1 Comment

Rx Brand Managers: Will Your Products Be Covered Under Obamacare?

by Tom Norton We are now less than three weeks away from the initial sign up period for Obamacare. After October 1st, the reality of the program and all that it portends for the future of the US pharmaceutical industry will begin to make itself apparent. One area that is of extreme concern to Rx […]
Posted in Guest Blog, healthcare, Legal, Market Access, Regulatory, Strategy | Also tagged , , , , , , , | Leave a comment

Your 2014 Medicaid Sales & Marketing Plans

by Tom Norton If you are an Rx regional sales director or a product marketing manager, I have a somewhat provocative question for you:  How exactly are you planning your 2014 Medicaid strategy?
Posted in Advertising, Guest Blog, healthcare, Legal, Market Access, Marketing, pricing, Regulatory, Sales, Strategy | Also tagged , , , , , , , , , | Leave a comment

Congress 'Tip Toes' Around Obamacare

by Tom Norton Of the many issues involved with the actual implementation of the 2010 Affordable Care Act, aka, “Obamacare”, few are more intriguing to me than those that personally impact Members of Congress (MOCs).  Here’s a good example of what I’m talking about — Today, on Capitol Hill, MOCs, along with thousands of their […]
Posted in Guest Blog, healthcare, Legal, Strategy | Also tagged , , , , , , , | 3 Comments
  • Categories

  • Meta